Kaopectate Liquid
NDC Package 55505-229-64

11-digit billing NDC: 55505022964

Package Information

Kaopectate (bismuth subsalicylate) liquids is shake well immediately before each useonly use pre-measured dose cupadults and children 12 years of age and older: 1 dose (30 mL) every hour as needed.do not exceed 4 doses (120 mL) in 24 hoursuse until diarrhea stops but not more than 2 dayschildren under 12 years: ask a doctordrink plenty of clear fluids to help prevent dehydration caused by diarrhea. This formulation utilizes a liquid delivery system. Marketed by Kramer Laboratories, this product is identified by NDC 55505-229 and is authorized under FDA application M008.

Identification & Billing

NDC Package Code
55505-229-64
Package Description
325 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
55505022964
RxNorm Crosswalk
  • RxCUI: 1043048 - Kaopectate Extra Strength 525 MG in 15 mL Oral Suspension, Reformulated Aug 2006
  • RxCUI: 1043048 - bismuth subsalicylate 35 MG/ML Oral Suspension [Kaopectate Reformulated Aug 2006]
  • RxCUI: 1043048 - Kaopectate 525 MG per 15 ML Oral Suspension, Reformulated Aug 2006
  • RxCUI: 1043048 - Kaopectate Reformulated Aug 2006 35 MG/ML Oral Suspension
  • RxCUI: 308763 - bismuth subsalicylate 1050 MG in 30 mL Oral Suspension

Clinical Specifications

Proprietary Name
Kaopectate
Non-Proprietary Name
Bismuth Subsalicylate
Substance Name
Bismuth Subsalicylate
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Shake well immediately before each useonly use pre-measured dose cupadults and children 12 years of age and older: 1 dose (30 mL) every hour as needed.do not exceed 4 doses (120 mL) in 24 hoursuse until diarrhea stops but not more than 2 dayschildren under 12 years: ask a doctordrink plenty of clear fluids to help prevent dehydration caused by diarrhea

Regulatory & Marketing

Labeler Name
Kramer Laboratories
Product Type
Human Otc Drug
FDA Application #
M008
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-01-2026
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55505-229-64 identifies a specific commercial package of 325 ml in 1 bottle of Kaopectate, a human over the counter drug labeled by Kramer Laboratories. This liquid is formulated for oral use and contains bismuth subsalicylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kramer Laboratories on February 01, 2026. The current certification is valid through December 31, 2026.

How is this Kramer Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55505022964. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55505-229-64
11-Digit CMS (5-4-2)
55505-0229-64

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.